Tapewire

NYSE · USD

MOH

MOLINA HEALTHCARE, INC.

Export transactions ↓
Tapewire entity
3504
SEC CIK
0001179929
Parsed reports
704

Last 12 months

Inside the activity.

1 purchase rows · 4 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202600
Feb 202610
Mar 202601
Apr 202600
May 202602
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 01, 2026 Filed Oct 3, 2026 00:47 UTC GrantCommon Stock 304 $180.85 $54,978.40
Disclosure

SEC source: 0001257996-26-000008 · wk-form4_1790974045.xml · nonDerivative · entry 1

GROHOWSKI LEO P · CIK 0001257996 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,846

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2026 was $180.85, which resulted in a grant of 304 shares.

F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2026.

Read SEC document
October 01, 2026 Filed Oct 3, 2026 00:48 UTC GrantCommon Stock 304 $180.85 $54,978.40
Disclosure

SEC source: 0001856013-26-000008 · wk-form4_1790974131.xml · nonDerivative · entry 1

Lockhart Stephen H · CIK 0001856013 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,688

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2026 was $180.85, which resulted in a grant of 304 shares.

F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2026.

Read SEC document
October 01, 2026 Filed Oct 3, 2026 00:50 UTC
ROMNEY RONNADirector
GrantCommon Stock 304 $180.85 $54,978.40
Disclosure

SEC source: 0001206684-26-000010 · wk-form4_1790974245.xml · nonDerivative · entry 1

ROMNEY RONNA · CIK 0001206684 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 18,173

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2026 was $180.85, which resulted in a grant of 304 shares.

F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2026.

F4 · ownership.nature: All shares held by Ronna Romney Revocable Trust.

Read SEC document
October 01, 2026 Filed Oct 3, 2026 00:46 UTC GrantCommon Stock 304 $180.85 $54,978.40
Disclosure

SEC source: 0001233184-26-000017 · wk-form4_1790973981.xml · nonDerivative · entry 1

SOISTMAN FRANCIS S JR · CIK 0001233184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,211

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2026 was $180.85, which resulted in a grant of 304 shares.

F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2026.

Read SEC document
October 01, 2026 Filed Oct 3, 2026 00:49 UTC GrantCommon Stock 304 $180.85 $54,978.40
Disclosure

SEC source: 0001211493-26-000008 · wk-form4_1790974190.xml · nonDerivative · entry 1

ORLANDO STEVEN J · CIK 0001211493 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 18,271

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2026 was $180.85, which resulted in a grant of 304 shares.

F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2026.

F4 · ownership.nature: Shares are held by Orlando Family Trust.

Read SEC document
October 01, 2026 Filed Oct 3, 2026 00:52 UTC GrantCommon Stock 304 $180.85 $54,978.40
Disclosure

SEC source: 0001649773-26-000008 · wk-form4_1790974324.xml · nonDerivative · entry 1

Schapiro Richard M · CIK 0001649773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,615

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2026 was $180.85, which resulted in a grant of 304 shares.

F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2026.

Read SEC document
October 01, 2026 Filed Oct 3, 2026 00:54 UTC GrantCommon Stock 304 $180.85 $54,978.40
Disclosure

SEC source: 0001263714-26-000011 · wk-form4_1790974468.xml · nonDerivative · entry 1

ZORETIC RICHARD C · CIK 0001263714 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 9,693

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2026 was $180.85, which resulted in a grant of 304 shares.

F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2026.

F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust.

Read SEC document
October 01, 2026 Filed Oct 3, 2026 00:53 UTC
WOLF DALE BDirector
GrantCommon Stock 304 $180.85 $54,978.40
Disclosure

SEC source: 0001228861-26-000010 · wk-form4_1790974396.xml · nonDerivative · entry 1

WOLF DALE B · CIK 0001228861 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Trust

Disclosed balance after: 15,937

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2026 was $180.85, which resulted in a grant of 304 shares.

F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2026.

F4 · ownership.nature: Shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee.

Read SEC document
October 01, 2026 Filed Oct 3, 2026 00:45 UTC GrantCommon Stock 304 $180.85 $54,978.40
Disclosure

SEC source: 0001169490-26-000008 · wk-form4_1790973906.xml · nonDerivative · entry 1

BRASIER BARBARA L · CIK 0001169490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,122

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2026 was $180.85, which resulted in a grant of 304 shares.

F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2026.

Read SEC document
July 01, 2026 Filed Jul 2, 2026 20:48 UTC GrantCommon Stock 237 $232.55 $55,114.35
Disclosure

SEC source: 0001169490-26-000006 · wk-form4_1783025337.xml · nonDerivative · entry 1

BRASIER BARBARA L · CIK 0001169490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,818

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares.

F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2026.

Read SEC document
July 01, 2026 Filed Jul 2, 2026 20:53 UTC GrantCommon Stock 237 $232.55 $55,114.35
Disclosure

SEC source: 0001263714-26-000009 · wk-form4_1783025633.xml · nonDerivative · entry 1

ZORETIC RICHARD C · CIK 0001263714 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 9,389

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares.

F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2026.

F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust.

Read SEC document
July 01, 2026 Filed Jul 2, 2026 20:53 UTC
WOLF DALE BDirector
GrantCommon Stock 237 $232.55 $55,114.35
Disclosure

SEC source: 0001228861-26-000008 · wk-form4_1783025589.xml · nonDerivative · entry 1

WOLF DALE B · CIK 0001228861 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Trust

Disclosed balance after: 15,633

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares.

F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2026.

F4 · ownership.nature: Shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee.

Read SEC document
July 01, 2026 Filed Jul 2, 2026 20:52 UTC GrantCommon Stock 237 $232.55 $55,114.35
Disclosure

SEC source: 0001649773-26-000006 · wk-form4_1783025550.xml · nonDerivative · entry 1

Schapiro Richard M · CIK 0001649773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,311

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares.

F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2026.

Read SEC document
July 01, 2026 Filed Jul 2, 2026 20:51 UTC
ROMNEY RONNADirector
GrantCommon Stock 237 $232.55 $55,114.35
Disclosure

SEC source: 0001206684-26-000008 · wk-form4_1783025502.xml · nonDerivative · entry 1

ROMNEY RONNA · CIK 0001206684 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 17,869

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares.

F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2026.

F4 · ownership.nature: All shares held by Ronna Romney Revocable Trust.

Read SEC document
July 01, 2026 Filed Jul 2, 2026 20:51 UTC GrantCommon Stock 237 $232.55 $55,114.35
Disclosure

SEC source: 0001211493-26-000006 · wk-form4_1783025468.xml · nonDerivative · entry 1

ORLANDO STEVEN J · CIK 0001211493 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 17,967

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares.

F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2026.

F4 · ownership.nature: Shares are held by Orlando Family Trust.

Read SEC document
July 01, 2026 Filed Jul 2, 2026 20:50 UTC GrantCommon Stock 237 $232.55 $55,114.35
Disclosure

SEC source: 0001856013-26-000006 · wk-form4_1783025437.xml · nonDerivative · entry 1

Lockhart Stephen H · CIK 0001856013 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,384

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares.

F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2026.

Read SEC document
July 01, 2026 Filed Jul 2, 2026 20:50 UTC GrantCommon Stock 237 $232.55 $55,114.35
Disclosure

SEC source: 0001257996-26-000006 · wk-form4_1783025401.xml · nonDerivative · entry 1

GROHOWSKI LEO P · CIK 0001257996 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,542

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares.

F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2026.

Read SEC document
July 01, 2026 Filed Jul 2, 2026 20:49 UTC GrantCommon Stock 237 $232.55 $55,114.35
Disclosure

SEC source: 0001233184-26-000013 · wk-form4_1783025368.xml · nonDerivative · entry 1

SOISTMAN FRANCIS S JR · CIK 0001233184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 907

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares.

F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2026.

Read SEC document
July 01, 2026 Filed Jul 2, 2026 20:46 UTC
Bacon DebraEVP, Medicaid
Tax withholdingCommon Stock 183 $232.55 $42,556.65
Disclosure

SEC source: 0002010075-26-000006 · wk-form4_1783025189.xml · nonDerivative · entry 2

Bacon Debra · CIK 0002010075 · EVP, Medicaid

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,636

F3 · kind: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 529 shares on July 1, 2026.

F4 · balance_after: The shares vest as follows: 4,977 shares on March 1, 2027; 4,220 shares on March 1, 2028; and 3,202 shares on March 1, 2029. The remaining shares are vested.

Read SEC document
June 30, 2026 Filed Jul 2, 2026 20:47 UTC
WOYS JAMESChief Operating Officer
GrantCommon Stock 144 $147.51 $21,241.44
Disclosure

SEC source: 0001213947-26-000004 · wk-form4_1783025266.xml · nonDerivative · entry 1

WOYS JAMES · CIK 0001213947 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,178

F1 · kind: The shares were acquired under the Molina Healthcare, Inc. 2019 Employee Stock Purchase Plan (the "ESPP").

F2 · price: In accordance with the ESPP, the purchase price is 85% of the closing price of the Issuer's common stock on January 1, 2026 of $173.54 (which represents the lower market price of the Issuer's common stock as of (i) January 1, 2026, the first date of the ESPP offering period, and (ii) June 30, 2026, the last trading day of the offering period).

F3 · balance_after: The shares vest as follows: 9,304 shares on March 1, 2027; 7,754 shares on March 1, 2028; and 5,672 shares on March 1, 2029. The remaining shares are vested.

Read SEC document
June 30, 2026 Filed Jul 2, 2026 20:47 UTC
Barlow Jeff D.Chief Legal Officer
GrantCommon Stock 138 $147.51 $20,356.38
Disclosure

SEC source: 0001555603-26-000006 · wk-form4_1783025225.xml · nonDerivative · entry 1

Barlow Jeff D. · CIK 0001555603 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,313

F1 · kind: The shares were acquired under the Molina Healthcare, Inc. 2019 Employee Stock Purchase Plan (the "ESPP").

F2 · price: In accordance with the ESPP, the purchase price is 85% of the closing price of the Issuer's common stock on January 1, 2026 of $173.54 (which represents the lower market price of the Issuer's common stock as of (i) January 1, 2026, the first date of the ESPP offering period, and (ii) June 30, 2026, the last trading day of the offering period).

F3 · balance_after: The shares vest as follows: 7,296 shares on March 1, 2027; 6,193 shares on March 1, 2028; and 4,574 shares on March 1, 2029. The remaining shares are vested.

Read SEC document
June 30, 2026 Filed Jul 2, 2026 20:46 UTC
Bacon DebraEVP, Medicaid
GrantCommon Stock 23 $147.51 $3,392.73
Disclosure

SEC source: 0002010075-26-000006 · wk-form4_1783025189.xml · nonDerivative · entry 1

Bacon Debra · CIK 0002010075 · EVP, Medicaid

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,819

F1 · kind: The shares were acquired under the Molina Healthcare, Inc. 2019 Employee Stock Purchase Plan (the "ESPP").

F2 · price: In accordance with the ESPP, the purchase price is 85% of the closing price of the Issuer's common stock on January 1, 2026 of $173.54 (which represents the lower market price of the Issuer's common stock as of (i) January 1, 2026, the first date of the ESPP offering period, and (ii) June 30, 2026, the last trading day of the offering period).

Read SEC document
May 14, 2026 Filed May 15, 2026 20:35 UTC
HEBERT MAURICEChief Accounting Officer
SaleCommon Stock 600 $191.55 $114,930.00
Disclosure

SEC source: 0001267043-26-000004 · wk-form4_1778877301.xml · nonDerivative · entry 1

HEBERT MAURICE · CIK 0001267043 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,815

F1 · price: Represents the selling price per share of all 600 shares.

F2 · balance_after: The shares vest as follows: 1,245 shares on March 1, 2027; 986 shares on March 1, 2028, and 686 shares on March 1, 2029. The remaining shares are vested.

Read SEC document
May 11, 2026 Filed May 13, 2026 20:36 UTC
Barlow Jeff D.Chief Legal Officer
SaleCommon Stock 17,811 $186.12 $3,314,983.32
Disclosure

SEC source: 0001555603-26-000004 · wk-form4_1778704585.xml · nonDerivative · entry 1

Barlow Jeff D. · CIK 0001555603 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,175

F1 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $186.01 to $186.86. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

F2 · balance_after: The shares vest as follows: 7,296 shares on March 1, 2027; 6,193 shares on March 1, 2028; and 4,574 shares on March 1, 2029. The remaining shares are vested.

Read SEC document
May 06, 2026 Filed May 8, 2026 20:36 UTC GrantCommon Stock 170 $197.44 $33,564.80
Disclosure

SEC source: 0001233184-26-000007 · wk-form4_1778272575.xml · nonDerivative · entry 1

SOISTMAN FRANCIS S JR · CIK 0001233184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 670

F1 · kind: Grant of stock under the Issuer's 2025 Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: Represents the prorated quarterly director grant. Mr. Soistman was elected as a director on May 6, 2026.

F3 · price: Represents the closing price of the Issuer's common stock on May 6, 2026.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 20:44 UTC GrantCommon Stock 405 $135.82 $55,007.10
Disclosure

SEC source: 0001169490-26-000004 · wk-form4_1775162648.xml · nonDerivative · entry 1

BRASIER BARBARA L · CIK 0001169490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,581

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2026 was $135.82, which resulted in a grant of 405 shares.

F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2026.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 20:49 UTC GrantCommon Stock 405 $135.82 $55,007.10
Disclosure

SEC source: 0001257996-26-000004 · wk-form4_1775162941.xml · nonDerivative · entry 1

GROHOWSKI LEO P · CIK 0001257996 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,305

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2026 was $135.82, which resulted in a grant of 405 shares.

F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2026.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 20:48 UTC GrantCommon Stock 405 $135.82 $55,007.10
Disclosure

SEC source: 0001856013-26-000004 · wk-form4_1775162898.xml · nonDerivative · entry 1

Lockhart Stephen H · CIK 0001856013 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,147

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2026 was $135.82, which resulted in a grant of 405 shares.

F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2026.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 20:47 UTC GrantCommon Stock 405 $135.82 $55,007.10
Disclosure

SEC source: 0001211493-26-000004 · wk-form4_1775162855.xml · nonDerivative · entry 1

ORLANDO STEVEN J · CIK 0001211493 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 17,730

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2026 was $135.82, which resulted in a grant of 405 shares.

F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2026.

F4 · ownership.nature: Shares are held by Orlando Family Trust.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 20:46 UTC
WOLF DALE BDirector
GrantCommon Stock 405 $135.82 $55,007.10
Disclosure

SEC source: 0001228861-26-000004 · wk-form4_1775162812.xml · nonDerivative · entry 1

WOLF DALE B · CIK 0001228861 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Trust

Disclosed balance after: 15,396

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2026 was $135.82, which resulted in a grant of 405 shares.

F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2026.

F4 · ownership.nature: Shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 20:46 UTC GrantCommon Stock 405 $135.82 $55,007.10
Disclosure

SEC source: 0001263714-26-000006 · wk-form4_1775162757.xml · nonDerivative · entry 1

ZORETIC RICHARD C · CIK 0001263714 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 9,152

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2026 was $135.82, which resulted in a grant of 405 shares.

F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2026.

F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 20:45 UTC GrantCommon Stock 405 $135.82 $55,007.10
Disclosure

SEC source: 0001649773-26-000004 · wk-form4_1775162705.xml · nonDerivative · entry 1

Schapiro Richard M · CIK 0001649773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,074

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2026 was $135.82, which resulted in a grant of 405 shares.

F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2026.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 20:43 UTC
ROMNEY RONNADirector
GrantCommon Stock 405 $135.82 $55,007.10
Disclosure

SEC source: 0001206684-26-000006 · wk-form4_1775162599.xml · nonDerivative · entry 1

ROMNEY RONNA · CIK 0001206684 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 17,632

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2026 was $135.82, which resulted in a grant of 405 shares.

F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2026.

F4 · ownership.nature: All shares held by Ronna Romney Revocable Trust.

Read SEC document
March 12, 2026 Filed Mar 13, 2026 20:36 UTC
ROMNEY RONNADirector
SaleCommon Stock 506 $146.92 $74,341.52
Disclosure

SEC source: 0001206684-26-000004 · wk-form4_1773434166.xml · nonDerivative · entry 1

ROMNEY RONNA · CIK 0001206684 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 17,227

F1 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $146.80 to $147.10. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

F2 · ownership.nature: All shares held by Ronna Romney Revocable Trust.

Read SEC document
March 01, 2026 Filed Mar 3, 2026 01:07 UTC
Zubretsky Joseph MDirector · President & CEO
GrantCommon Stock 66,417 $145.75 $9,680,277.75
Disclosure

SEC source: 0001320929-26-000002 · wk-form4_1772500032.xml · nonDerivative · entry 2

Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,015

F3 · shares: Grant of restricted stock under the Issuer's 2025 Equity Incentive Plan.

F4 · price: Represents the volume-weighted average price (VWAP) of the Company's common stock for the ten (10) trading dates immediately preceding the March 1, 2026 grant date.

F5 · balance_after: The shares shall vest as follows: The 66,417 newly granted shares shall vest in one-third increments on each of March 1, 2027, March 1, 2028, and March 1, 2029. Additional shares shall vest as follows: 13,075 shares on March 1, 2027; and 7,497 shares on March 1, 2028. The remaining shares are vested.

Read SEC document
March 01, 2026 Filed Mar 3, 2026 01:07 UTC
Zubretsky Joseph MDirector · President & CEO
Tax withholdingCommon Stock 8,597 $154.05 $1,324,367.85
Disclosure

SEC source: 0001320929-26-000002 · wk-form4_1772500032.xml · nonDerivative · entry 1

Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,598

F1 · shares: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 20,623 shares on March 1, 2026.

F2 · price: Represents the closing price of the Issuer's common stock on February 27, 2026.

Read SEC document
March 01, 2026 Filed Mar 3, 2026 01:06 UTC
Keim Mark LowellChief Financial Officer
GrantCommon Stock 26,073 $145.75 $3,800,139.75
Disclosure

SEC source: 0001690677-26-000002 · wk-form4_1772499999.xml · nonDerivative · entry 2

Keim Mark Lowell · CIK 0001690677 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,251

F3 · shares: Grant of restricted stock under the Issuer's 2025 Equity Incentive Plan.

F4 · price: Represents the volume-weighted average price (VWAP) of the Company's common stock for the ten (10) trading dates immediately preceding the March 1, 2026 grant date.

F5 · balance_after: The shares shall vest as follows: The 26,073 newly granted shares shall vest in one-third increments on each of March 1, 2027, March 1, 2028, and March 1, 2029. Additional shares shall vest as follows: 4,613 shares on March 1, 2027; and 2,892 shares on March 1, 2028. The remaining shares are vested.

Read SEC document
March 01, 2026 Filed Mar 3, 2026 01:06 UTC
Keim Mark LowellChief Financial Officer
Tax withholdingCommon Stock 2,308 $154.05 $355,547.40
Disclosure

SEC source: 0001690677-26-000002 · wk-form4_1772499999.xml · nonDerivative · entry 1

Keim Mark Lowell · CIK 0001690677 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,178

F1 · shares: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 6,563 shares on March 1, 2026.

F2 · price: Represents the closing price of the Issuer's common stock on February 27, 2026.

Read SEC document
March 01, 2026 Filed Mar 3, 2026 01:01 UTC
HEBERT MAURICEChief Accounting Officer
GrantCommon Stock 2,058 $145.75 $299,953.50
Disclosure

SEC source: 0001267043-26-000002 · wk-form4_1772499679.xml · nonDerivative · entry 4

HEBERT MAURICE · CIK 0001267043 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,415

F5 · shares: Grant of restricted stock under the Issuer's 2025 Equity Incentive Plan.

F6 · price: Represents the volume-weighted average price (VWAP) of the Company's common stock for the ten (10) trading dates immediately preceding the March 1, 2026 grant date.

F7 · balance_after: The shares shall vest as follows: The 2,058 newly granted shares shall vest in one-third increments on each of March 1, 2027, March 1, 2028, and March 1, 2029. Additional shares shall vest as follows: 559 shares on March 1, 2027; and 300 shares on March 1, 2028. The remaining shares are vested.

Read SEC document
March 01, 2026 Filed Mar 3, 2026 01:01 UTC
HEBERT MAURICEChief Accounting Officer
Tax withholdingCommon Stock 272 $154.05 $41,901.60
Disclosure

SEC source: 0001267043-26-000002 · wk-form4_1772499679.xml · nonDerivative · entry 3

HEBERT MAURICE · CIK 0001267043 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,357

F4 · shares: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 802 shares on March 1, 2026.

F2 · price: Represents the closing price of the Issuer's common stock on February 27, 2026.

Read SEC document
March 01, 2026 Filed Mar 3, 2026 01:01 UTC
HEBERT MAURICEChief Accounting Officer
Tax withholdingCommon Stock 229 $154.05 $35,277.45
Disclosure

SEC source: 0001267043-26-000002 · wk-form4_1772499679.xml · nonDerivative · entry 2

HEBERT MAURICE · CIK 0001267043 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,629

F3 · shares: The shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units.

F2 · price: Represents the closing price of the Issuer's common stock on February 27, 2026.

Read SEC document
March 01, 2026 Filed Mar 3, 2026 01:01 UTC
HEBERT MAURICEChief Accounting Officer
GrantCommon Stock 650 $154.05 $100,132.50
Disclosure

SEC source: 0001267043-26-000002 · wk-form4_1772499679.xml · nonDerivative · entry 1

HEBERT MAURICE · CIK 0001267043 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,858

F1 · shares: Shares issued in settlement of performance stock units granted on March 1, 2023, based on the Company's achievement of three-year average adjusted earnings per share, at 89% vesting level.

F2 · price: Represents the closing price of the Issuer's common stock on February 27, 2026.

Read SEC document
March 01, 2026 Filed Mar 3, 2026 01:05 UTC
WOYS JAMESChief Operating Officer
GrantCommon Stock 17,016 $145.75 $2,480,082.00
Disclosure

SEC source: 0001213947-26-000002 · wk-form4_1772499951.xml · nonDerivative · entry 2

WOYS JAMES · CIK 0001213947 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,034

F3 · shares: Grant of restricted stock under the Issuer's 2025 Equity Incentive Plan.

F4 · price: Represents the volume-weighted average price (VWAP) of the Company's common stock for the ten (10) trading dates immediately preceding the March 1, 2026 grant date.

F5 · balance_after: The shares shall vest as follows: The 17,016 newly granted shares shall vest in one-third increments on each of March 1, 2027, March 1, 2028, and March 1, 2029. Additional shares shall vest as follows: 3,632 shares on March 1, 2027; and 2,082 shares on March 1, 2028. The remaining shares are vested.

Read SEC document
March 01, 2026 Filed Mar 3, 2026 01:05 UTC
WOYS JAMESChief Operating Officer
Tax withholdingCommon Stock 1,313 $154.05 $202,267.65
Disclosure

SEC source: 0001213947-26-000002 · wk-form4_1772499951.xml · nonDerivative · entry 1

WOYS JAMES · CIK 0001213947 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,018

F1 · shares: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 5,337 shares on March 1, 2026.

F2 · price: Represents the closing price of the Issuer's common stock on February 27, 2026.

Read SEC document
March 01, 2026 Filed Mar 3, 2026 00:59 UTC
Barlow Jeff D.Chief Legal Officer
GrantCommon Stock 13,722 $145.75 $1,999,981.50
Disclosure

SEC source: 0001555603-26-000002 · wk-form4_1772499539.xml · nonDerivative · entry 2

Barlow Jeff D. · CIK 0001555603 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,986

F3 · shares: Grant of restricted stock under the Issuer's 2025 Equity Incentive Plan.

F4 · price: Represents the volume-weighted average price (VWAP) of the Company's common stock for the ten (10) trading dates immediately preceding the March 1, 2026 grant date.

F5 · balance_after: The shares shall vest as follows: The 13,722 newly granted shares shall vest in one-third increments on each of March 1, 2027, March 1, 2028, and March 1, 2029. Additional shares shall vest as follows: 2,722 shares on March 1, 2027; and 1,619 shares on March 1, 2028. The remaining shares are vested.

Read SEC document
March 01, 2026 Filed Mar 3, 2026 00:59 UTC
Barlow Jeff D.Chief Legal Officer
Tax withholdingCommon Stock 1,638 $154.05 $252,333.90
Disclosure

SEC source: 0001555603-26-000002 · wk-form4_1772499539.xml · nonDerivative · entry 1

Barlow Jeff D. · CIK 0001555603 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,264

F1 · shares: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 4,183 shares on March 1, 2026.

F2 · price: Represents the closing price of the Issuer's common stock on February 27, 2026.

Read SEC document
March 01, 2026 Filed Mar 3, 2026 00:58 UTC
Bacon DebraEVP, Medicaid
GrantCommon Stock 9,606 $145.75 $1,400,074.50
Disclosure

SEC source: 0002010075-26-000004 · wk-form4_1772499486.xml · nonDerivative · entry 2

Bacon Debra · CIK 0002010075 · EVP, Medicaid

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,796

F3 · shares: Grant of restricted stock under the Issuer's 2025 Equity Incentive Plan.

F4 · price: Represents the volume-weighted average price (VWAP) of the Company's common stock for the ten (10) trading dates immediately preceding the March 1, 2026 grant date.

F5 · balance_after: The shares shall vest as follows: The 9,606 newly granted shares shall vest in one-third increments on each of March 1, 2027, March 1, 2028, and March 1, 2029. Additional shares shall vest as follows: 529 shares on July 1, 2026; 1,775 shares on March 1, 2027; and 1,018 on March 1, 2028. The remaining shares are vested.

Read SEC document
March 01, 2026 Filed Mar 3, 2026 00:58 UTC
Bacon DebraEVP, Medicaid
Tax withholdingCommon Stock 716 $154.05 $110,299.80
Disclosure

SEC source: 0002010075-26-000004 · wk-form4_1772499486.xml · nonDerivative · entry 1

Bacon Debra · CIK 0002010075 · EVP, Medicaid

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,190

F1 · shares: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 2,021 shares on March 1, 2026.

F2 · price: Represents the closing price of the Issuer's common stock on February 27, 2026.

Read SEC document
February 11, 2026 Filed Feb 13, 2026 01:27 UTC PurchaseCommon Stock 800 $125.16 $100,128.00
Disclosure

SEC source: 0001263714-26-000004 · wk-form4_1770946064.xml · nonDerivative · entry 1

ZORETIC RICHARD C · CIK 0001263714 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 8,747

F1 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust.

Read SEC document
January 01, 2026 Filed Jan 2, 2026 21:49 UTC GrantCommon Stock 317 $173.54 $55,012.18
Disclosure

SEC source: 0001169490-26-000002 · wk-form4_1767390592.xml · nonDerivative · entry 1

BRASIER BARBARA L · CIK 0001169490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,176

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2026, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2025, of $173.54. Thus, the grant this quarter for services as a Director is for 317 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2025.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.